Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change Price Change
grade B 226.56 0.19% 0.42
ABMD closed up 1.0 percent on Monday, June 1, 2020, on 60 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical ABMD trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.19%
Above Upper BB Strength 0.19%
Overbought Stochastic Strength 0.19%
Up 3 Days in a Row Strength 0.19%
Upper Bollinger Band Touch Strength 0.19%
Pocket Pivot Bullish Swing Setup 1.19%
Upper Bollinger Band Walk Strength 1.19%
Above Upper BB Strength 1.19%
Overbought Stochastic Strength 1.19%
Upper Bollinger Band Touch Strength 1.19%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Medicine Medical Specialties Catheter Circulatory System Prosthetics Interventional Cardiology Cardiology Heart Diseases Acute Heart Failure Heart Attack

Is ABMD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 285.77
52 Week Low 119.0101
Average Volume 595,557
200-Day Moving Average 178.48
50-Day Moving Average 172.76
20-Day Moving Average 196.76
10-Day Moving Average 206.49
Average True Range 8.20
ADX 42.5
+DI 43.93
-DI 11.71
Chandelier Exit (Long, 3 ATRs ) 202.25
Chandelier Exit (Short, 3 ATRs ) 193.88
Upper Bollinger Band 223.33
Lower Bollinger Band 170.18
Percent B (%b) 1.05
BandWidth 27.01
MACD Line 12.91
MACD Signal Line 10.31
MACD Histogram 2.5922
Fundamentals Value
Market Cap 9.98 Billion
Num Shares 44.1 Million
EPS 1.71
Price-to-Earnings (P/E) Ratio 132.25
Price-to-Sales 16.68
Price-to-Book 13.96
PEG Ratio 2.75
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 235.18
Resistance 3 (R3) 234.41 230.63 233.67
Resistance 2 (R2) 230.63 228.33 231.01 233.17
Resistance 1 (R1) 228.38 226.91 229.51 229.15 232.67
Pivot Point 224.61 224.61 225.17 224.99 224.61
Support 1 (S1) 222.36 222.30 223.48 223.13 219.61
Support 2 (S2) 218.58 220.88 218.96 219.11
Support 3 (S3) 216.34 218.58 218.61
Support 4 (S4) 217.10